Canadian real-world experience of Asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.

Publication date: Available online 22 August 2023Source: Leukemia ResearchAuthor(s): Fatima M Khadadah, Sonia Cerquozzi, Harold J. Olney, Christina Fraga, Jill Dudebout, Anargyros Xenocostas, Nicholas Finn, Vincent Ethier, M. Lynn Savoie, Lambert Busqu…